# Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

> **NCT00466791** · PHASE2 · COMPLETED · sponsor: **Noven Therapeutics** · enrollment: 93 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Methylphenidate Transdermal System

## Key facts

- **NCT ID:** NCT00466791
- **Lead sponsor:** Noven Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466791, "Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00466791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*